Matches a patient's disease profile to the treatments most likely to produce an effective response.
Consented intake · your records travel with you · nothing moves without your sign-off
Leal Health provides biomarker-drug matching for cancer patients. Using the disease profile from a patient's test data, it recommends the treatment options judged most likely to bring an effective response. It serves patients who want their choices informed by broad global thinking, with predicted treatment response and an assessment of confidence in the outcome to weigh alongside their doctor's advice.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Leal Health handles billing.
We don't have confirmed insurance details for Leal Health yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Leal's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Finds clinical trials you actually qualify for — matched to your tumor's biomarkers and treatment history, not a generic keyword search.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.